AstraZeneca's Ticagrelor Gets Positive EU Recommendation, But FDA Could Catch Up Soon
This article was originally published in The Pink Sheet Daily
Executive Summary
Europe's CHMP recommends ticagrelor for patients with acute coronary syndromes, while FDA still grapples with lack of effect in North American patients.